(Q39285839)

10 September 2017

Vinorelbine inhibits angiogenesis and 95D migration via reducing hypoxic fibroblast stromal cell-derived factor 1 secretion (English)

1 reference

10 September 2017

0 references

Dongdong Fang

1

1 reference

10 September 2017

Li Sun

2

1 reference

10 September 2017

Sensen Lin

3

1 reference

10 September 2017

Liqiang Zhou

4

1 reference

10 September 2017

Nan Su

5

1 reference

10 September 2017

Shengtao Yuan

6

1 reference

10 September 2017

Boyang Yu

7

1 reference

10 September 2017

3 September 2012

1 reference

Experimental Biology and Medicine

10 September 2017

1 reference

10 September 2017

237

1 reference

10 September 2017

9

1 reference

10 September 2017

1045-1055

1 reference

Stromal fibroblasts in cancer initiation and progression

10 September 2017

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Cancer-associated stromal fibroblasts promote pancreatic tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Hypoxic activation of adventitial fibroblasts: role in vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Hypoxia induces differentiation of pulmonary artery adventitial fibroblasts into myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

21 January 2018

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Stromal fibroblasts in cancer: a novel tumor-promoting cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

CXCR4 signaling in the regulation of stem cell migration and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Regulation of the chemokine receptor CXCR4 by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Safety and efficacy of vinorelbine in the treatment of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

A novel Ca2+/calmodulin antagonist HBC inhibits angiogenesis and down-regulates hypoxia-inducible factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Clinical use of therapies targeting tumor vasculature and stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Imatinib mesylate inhibits proliferation and exerts an antifibrotic effect in human breast stroma fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Angiogenesis as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

CXCL12 (SDF-1)/CXCR4 pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypox

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Role of chemokines in tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Stromal cell-derived factor-1 expression in pituitary adenoma tissues and upregulation in hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Crosstalk to stromal fibroblasts induces resistance of lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.012037

21 January 2018

Identifiers

DOI

10.1258/EBM.2012.012037

1 reference

release_tvxhi2vgyfgczc7wdw3ut5sjem

10 September 2017

0 references

1 reference